Vaxart amends bylaws: reduces stockholder quorum to one-third, updates advance notice

Vaxart, Inc.

Board adopted amended bylaws effective Oct 18, 2023 to conform to DGCL amendments.
Quorum reduced from majority to at least one-third of outstanding voting shares.
Advance notice provisions updated per Rule 14a-19 universal proxy rules.
Stockholder notices for nominations/business proposals must now be in writing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Vaxart, Inc.: Amended and restated bylaws to conform to recent DGCL amendments, reduce stockholder meeting quorum from majority to at least one-third, update advance notice provisions for nominations and other business, and make other clarifying and procedural changes (effective 2023-10-18).

Change: bylaw amendment
Effective: 2023-10-18

Exact text from the filing

On October 18, 2023, the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”) approved and adopted the Amended and Restated Bylaws of the Company (the “Bylaws”), effective [immediately], to update the bylaws to conform certain provisions to the Delaware General Corporation Law (the “DGCL”) in light of, among other things, recent amendments to the DGCL, to make clarifying changes, and to effect certain other changes regarding internal procedural matters, including the following changes

View on SEC.gov

Browse all governance changes →

Vaxart, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-028774

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.